Viridian Therapeutics Market Sentiment

Viridian Therapeutics Inc

VRDNNASDAQ

Trade with Public

$22.37

-0.45-1.97%

마지막 업데이트: Oct 23, 4:04 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

실적: Q3 2026 실적이 수 11월 4th에 개장 전 12일 후 후에 발표됩니다.

Viridian Therapeutics Market Sentiment - Benzinga

Viridian Therapeutics Market Sentiment

Market sentiment signals for Viridian Therapeutics (VRDN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 16.4% short float

Options Flow▼ 42.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

19 analysts

Options Flow (P/C)

42.00

More puts — Bearish

1 calls · 42 puts

Avg Consensus PT

$37

+67.2%

Highest Price Target

$61

+172.7%

BTIG

Lowest Price Target

$20

-10.6%

B. Riley Securities

Short Interest

16.4%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 22, 2026	RBC Capital	Lisa Walter—	+69.9%	$36 → $38	Maintained	Outperform
Aug 7, 2026	RBC Capital	Lisa Walter—	+60.9%	$35 → $36	Maintained	Outperform
Aug 7, 2026	Truist Securities	Gregory Renza—	+74.3%	$38 → $39	Maintained	Buy
Jun 30, 2026	RBC Capital	Lisa Walter—	+56.5%	$34 → $35	Maintained	Outperform
Jun 30, 2026	Truist Securities	Gregory Renza—	+69.9%	$35 → $38	Maintained	Buy
Jun 30, 2026	Wedbush	Laura Chico—	+92.2%	$32 → $43	Maintained	Outperform
Jun 30, 2026	Needham	Serge Belanger—	+52.0%	$32 → $34	Maintained	Buy
Jun 29, 2026	Wells Fargo	Derek Archila—	+38.6%	$20 → $31	Upgrade	Equal-Weight→Overweight
Jun 29, 2026	Needham	Serge Belanger—	+43.0%	$32 → $32	Maintained	Buy
May 15, 2026	Evercore ISI Group	Maneka Mirchandaney—	+16.2%	$27 → $26	Maintained	Outperform
May 6, 2026	RBC Capital	Lisa Walter—	+52.0%	$30 → $34	Maintained	Outperform
May 5, 2026	Needham	Serge Belanger—	+43.0%	$32 → $32	Maintained	Buy
Apr 21, 2026	Truist Securities	Gregory Renza—	+47.5%	$36 → $33	Maintained	Buy
Apr 8, 2026	Wedbush	Laura Chico—	+38.6%	$37 → $31	Maintained	Outperform
Apr 7, 2026	Goldman Sachs	Richard Law—	+38.6%	$36 → $31	Maintained	Buy
Apr 7, 2026	RBC Capital	Lisa Walter—	+34.1%	$42 → $30	Maintained	Outperform
Apr 2, 2026	Evercore ISI Group	Maneka Mirchandaney—	+43.0%	$45 → $32	Maintained	Outperform
Mar 31, 2026	Goldman Sachs	Richard Law—	+60.9%	$41 → $36	Maintained	Buy
Mar 31, 2026	Wedbush	Laura Chico—	+65.4%	$44 → $37	Maintained	Outperform
Mar 31, 2026	Wells Fargo	Derek Archila—	-10.6%	$29 → $20	Maintained	Equal-Weight
Mar 31, 2026	HC Wainwright & Co.	Douglas Tsao—	-1.7%	$34 → $22	Maintained	Buy
Mar 30, 2026	Needham	Serge Belanger—	+43.0%	$42 → $32	Maintained	Buy
Mar 11, 2026	Wedbush	Laura Chico—	+96.7%	$44 → $44	Maintained	Outperform
Feb 27, 2026	RBC Capital	Lisa Walter—	+87.8%	$45 → $42	Maintained	Outperform
Feb 4, 2026	Needham	Serge Belanger—	+87.8%	$42 → $42	Maintained	Buy